Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Steven Knapper, DM, FRCPath, MRCP, BMBCh, Cardiff University, Cardiff, UK, discusses the challenges of acute myeloid leukemia (AML) that progresses from myeloproliferative neoplasms (MPNs). This interview took place at the MPN Advances Day 2019 in London, UK.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.